S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
NYSE:NVST

Envista Stock Forecast, Price & News

$43.22
+0.34 (+0.79%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$41.04
$43.35
50-Day Range
$38.15
$46.74
52-Week Range
$33.75
$46.88
Volume
1.87 million shs
Average Volume
1.37 million shs
Market Capitalization
$6.97 billion
P/E Ratio
20.78
Dividend Yield
N/A
Beta
1.75
30 days | 90 days | 365 days | Advanced Chart
Receive NVST News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.


Envista logo

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.

Headlines

Short Interest in Envista Holdings Co. (NYSE:NVST) Rises By 17.8%
January 20, 2022 |  americanbankingnews.com
Envista Schedules Fourth Quarter 2021 Earnings Call
January 19, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Employees
12,400
Year Founded
N/A

Sales & Book Value

Annual Sales
$2.28 billion
Cash Flow
$1.97 per share
Book Value
$23.31 per share

Profitability

Net Income
$33.30 million
Pretax Margin
11.75%

Debt

Price-To-Earnings

Miscellaneous

Free Float
160,045,000
Market Cap
$6.97 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
1/25/2022
Next Earnings (Confirmed)
2/09/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.81 out of 5 stars

Medical Sector

844th out of 1,415 stocks

Dental Equipment & Supplies Industry

5th out of 5 stocks

Analyst Opinion: 2.3Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 2.5 5 -4 -3 -2 -1 -












Envista (NYSE:NVST) Frequently Asked Questions

Is Envista a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Envista stock.
View analyst ratings for Envista
or view top-rated stocks.

How has Envista's stock price been impacted by COVID-19 (Coronavirus)?

Envista's stock was trading at $19.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NVST stock has increased by 116.9% and is now trading at $43.22.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Envista?

Envista saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 12,800,000 shares, an increase of 17.8% from the December 15th total of 10,870,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is presently 10.6 days. Approximately 8.0% of the shares of the stock are short sold.
View Envista's Short Interest
.

When is Envista's next earnings date?

Envista is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Envista
.

How can I listen to Envista's earnings call?

Envista will be holding an earnings conference call on Wednesday, February 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) issued its earnings results on Wednesday, November, 3rd. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.05. The firm earned $607.30 million during the quarter, compared to analyst estimates of $676.69 million. Envista had a trailing twelve-month return on equity of 9.52% and a net margin of 13.02%. During the same quarter in the prior year, the firm posted $0.48 earnings per share.
View Envista's earnings history
.

What guidance has Envista issued on next quarter's earnings?

Envista issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.48 billion-$2.50 billion, compared to the consensus revenue estimate of $2.81 billion.

What price target have analysts set for NVST?

4 brokers have issued 12 month price targets for Envista's stock. Their forecasts range from $45.00 to $55.00. On average, they anticipate Envista's share price to reach $48.75 in the next twelve months. This suggests a possible upside of 12.8% from the stock's current price.
View analysts' price targets for Envista
or view top-rated stocks among Wall Street analysts.

Who are Envista's key executives?

Envista's management team includes the following people:

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista CEO Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among Envista's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

(NVST) raised $603 million in an IPO on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

What is Envista's stock symbol?

Envista trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVST."

Who are Envista's major shareholders?

Envista's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Frontier Capital Management Co. LLC (0.35%), Retirement Systems of Alabama (0.31%), Wedge Capital Management L L P NC (0.12%), DNB Asset Management AS (0.04%), Russell Investments Group Ltd. (0.04%) and New York State Teachers Retirement System (0.03%). Company insiders that own Envista stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance and Mischa Reis.
View institutional ownership trends for Envista
.

Which major investors are selling Envista stock?

NVST stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, DNB Asset Management AS, Frontier Capital Management Co. LLC, Strs Ohio, Russell Investments Group Ltd., State of Alaska Department of Revenue, Cutler Group LP, and Eagle Bay Advisors LLC. Company insiders that have sold Envista company stock in the last year include Amir Aghdaei, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, and Mischa Reis.
View insider buying and selling activity for Envista
or view top insider-selling stocks.

Which major investors are buying Envista stock?

NVST stock was bought by a variety of institutional investors in the last quarter, including Sciencast Management LP, New York State Teachers Retirement System, Pendal Group Ltd, Crossmark Global Holdings Inc., Retirement Systems of Alabama, Midwest Wealth Management Inc., Outlook Wealth Advisors LLC, and Louisiana State Employees Retirement System.
View insider buying and selling activity for Envista
or or view top insider-buying stocks.

How do I buy shares of Envista?

Shares of NVST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Envista's stock price today?

One share of NVST stock can currently be purchased for approximately $43.22.

How much money does Envista make?

Envista has a market capitalization of $6.97 billion and generates $2.28 billion in revenue each year. The company earns $33.30 million in net income (profit) each year or $2.08 on an earnings per share basis.

How many employees does Envista have?

Envista employs 12,400 workers across the globe.

What is Envista's official website?

The official website for Envista is www.envistaco.com.

Where are Envista's headquarters?

How can I contact Envista?

Envista's mailing address is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. The company can be reached via phone at 714-817-7000, via email at [email protected], or via fax at 714-817-5450.


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.